Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 21515629)


Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis.

Chauffier K, Salliot C, Berenbaum F, Sellam J.

Rheumatology (Oxford). 2012 Jan;51(1):60-8. doi: 10.1093/rheumatology/ker162. Epub 2011 Apr 22. Review.


The effect of anti-TNF-α vs. DMARDs on fatigue in rheumatoid arthritis patients.

van Hoogmoed D, Fransen J, Repping-Wuts H, Spee L, Bleijenberg G, van Riel PL.

Scand J Rheumatol. 2013;42(1):15-9. doi: 10.3109/03009742.2012.709878. Epub 2012 Sep 20.


Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.

Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group.

Arthritis Rheum. 2006 Sep;54(9):2793-806.


A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Choy EH, Smith C, Doré CJ, Scott DL.

Rheumatology (Oxford). 2005 Nov;44(11):1414-21. Epub 2005 Jul 19. Review.


Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis.

Salliot C, Finckh A, Katchamart W, Lu Y, Sun Y, Bombardier C, Keystone E.

Ann Rheum Dis. 2011 Feb;70(2):266-71. doi: 10.1136/ard.2010.132134. Epub 2010 Nov 19. Review. Erratum in: Ann Rheum Dis. 2011 Mar;70(3):560.


Fatigue in rheumatoid arthritis reflects pain, not disease activity.

Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL.

Rheumatology (Oxford). 2006 Jul;45(7):885-9. Epub 2006 Jan 31.


The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.

Finckh A, Dehler S, Gabay C; SCQM doctors.

Ann Rheum Dis. 2009 Jan;68(1):33-9. doi: 10.1136/ard.2007.085696. Epub 2008 Jan 29.


A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.

Ma MH, Kingsley GH, Scott DL.

Rheumatology (Oxford). 2010 Jan;49(1):91-8. doi: 10.1093/rheumatology/kep331. Epub 2009 Nov 16. Review.


The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials.

Lee YH, Bae SC, Song GG.

Rheumatol Int. 2011 Nov;31(11):1493-9. doi: 10.1007/s00296-010-1526-y. Epub 2010 May 16. Review.


The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Clark W, Jobanputra P, Barton P, Burls A.

Health Technol Assess. 2004 May;8(18):iii-iv, ix-x, 1-105. Review.


Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.


A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach.

Schmitz S, Adams R, Walsh CD, Barry M, FitzGerald O.

Ann Rheum Dis. 2012 Feb;71(2):225-30. doi: 10.1136/annrheumdis-2011-200228. Epub 2011 Sep 29.


Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs.

Bergman GJ, Hochberg MC, Boers M, Wintfeld N, Kielhorn A, Jansen JP.

Semin Arthritis Rheum. 2010 Jun;39(6):425-41. doi: 10.1016/j.semarthrit.2009.12.002. Epub 2010 Mar 11. Review.


Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL.

Rheumatology (Oxford). 2002 Apr;41(4):430-9.


Assessing the cost-effectiveness of biologic agents for the management of moderate-to-severe rheumatoid arthritis in anti-TNF inadequate responders in Italy: a modelling approach.

Cimmino MA, Leardini G, Salaffi F, Intorcia M, Bellatreccia A, Dupont D, Beresniak A.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4):633-41. Epub 2011 Aug 31.


Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.

Mease PJ, Revicki DA, Szechinski J, Greenwald M, Kivitz A, Barile-Fabris L, Kalsi J, Eames J, Leirisalo-Repo M.

J Rheumatol. 2008 Jan;35(1):20-30. Epub 2007 Nov 15.


[Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFalpha agents failed are associated with response to rituximab in rheumatoid arthritis].

Quartuccio L, Salvin S, Saracco M, Lombardi S, Fabris M, Mansutti E, Maset M, Pellerito S, De Vita S.

Reumatismo. 2009 Jul-Sep;61(3):182-6. Italian.


Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial.

Westhovens R, Cole JC, Li T, Martin M, Maclean R, Lin P, Blaisdell B, Wallenstein GV, Aranda R, Sherrer Y.

Rheumatology (Oxford). 2006 Oct;45(10):1238-46. Epub 2006 Mar 27.


The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review.

Moots RJ, Naisbett-Groet B.

Rheumatology (Oxford). 2012 Dec;51(12):2252-61. doi: 10.1093/rheumatology/kes217. Epub 2012 Sep 1. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk